|
|
Volumn 93, Issue 5, 1996, Pages 843-846
|
|
Meeting highlights: American Heart Association 68th Scientific Sessions, Anaheim, California, November 13 to 15, 1995
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
ATRIAL NATRIURETIC FACTOR;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CARVEDILOL;
DIGITALIS;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
FELODIPINE;
FIBRINOLYTIC AGENT;
HEPARIN;
HIRUDIN;
LOW MOLECULAR WEIGHT HEPARIN;
PLACEBO;
REGULATOR PROTEIN;
STREPTOKINASE;
THROMBIN INHIBITOR;
TISSUE PLASMINOGEN ACTIVATOR;
TROPONIN I;
TROPONIN T;
ACUTE HEART INFARCTION;
ADULT;
AGED;
ATHERECTOMY;
BLEEDING;
CARDIOMYOPATHY;
CARDIOVASCULAR DISEASE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY THROMBOSIS;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
EXERCISE TEST;
FEMALE;
FIBRINOLYTIC THERAPY;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NOTE;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
SURVIVAL RATE;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
CONFERENCE PAPER;
HEART DISEASE;
HEART DISEASES;
HUMANS;
|
|
EID: 0030098013
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.93.5.843 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|
